Case Report: Successful treatment of severe pneumocystis carinii pneumonia in a case series of primary nephrotic syndrome after receiving anti-CD20 monoclonal antibody therapy [PDF]
Frontiers in Pediatrics, 2023 Rituximab is emerging as a new steroid sparing agent in children with difficult-to-treat nephrotic syndrome due to its ability of depleting CD20-positive B cells.
Lili Liu +8 more
doaj +2 more sources
Case Report: Pneumocystis jiroveci pneumonia: report of five children with the nephrotic syndrome and review of the literature [PDF]
Frontiers in PediatricsObjectiveTo retrospectively analyze the clinical characteristics, treatment, and prognosis of five pediatric patients with nephrotic syndrome who developed Pneumocystis carinii pneumonia (PJP) after long-term use of steroids and tacrolimus.MethodsA ...
Peitong Han +4 more
doaj +2 more sources
Absolute lymphocyte count as a predictor of Pneumocystis pneumonia in patients previously unknown to have HIV [PDF]
Journal of Community Hospital Internal Medicine Perspectives, 2012 This is a retrospective review of patients admitted to an inner city community hospital with community-acquired pneumonia who were ultimately diagnosed with AIDS and Pneumocystis. Absolute lymphocyte count in our hospital is available immediately.
Robert P. Ferguson, Aghogho A. Omene
doaj +1 more source
The Iraqi Journal of Medical Sciences, 2016 Background: Pneumocystis carinii is one of the rare fungi which cause pneumonia in immunocompromised patients. It is important to detect the fungus from the clinical specimens of suspected patients by laboratory tests. Objective:To identify Pneumocystis
Manahil M. Yehia +1 more
doaj +4 more sources
Immunization with Pneumocystis carinii A121–85 antigen activates immune function against P. carinii
BMC Immunology, 2021 Background Pneumocystis pneumonia (PcP), which is caused by Pneumocystis carinii, is a life-threatening infection that affects immunocompromised individuals. Unfortunately, chemoprophylaxis and dapsone are only effective for half of the patients with PcP,
Tong Tong +3 more
doaj +1 more source
Noninvasive Method for Monitoring Pneumocystis carinii Pneumonia
Emerging Infectious Diseases, 2003 The progression of Pneumocystis carinii pneumonia was temporally monitored and quantified by real-time polymerase chain reaction of P. carinii–specific DNA in oral swabs and lung homogenates from infected rats. DNA levels correlated with the number of P.
Michael J. Linke +4 more
doaj +1 more source
Risk Factors for Breakthrough Pneumocystis carinii Pneumonia on Aerosol Pentamidine Prophylaxis
Canadian Respiratory Journal, 1995 OBJECTIVE: To identify baseline characteristics of human immunodeficiency virus (HIV)-infected individuals on aerosol pentamidine for Pneumocystis carinii prophylaxis that are predictive of subsequent breakthrough Pneumocystis carinii pneumonia (PCP).
RA McIvor +4 more
doaj +1 more source
Sulfa Resistance and Dihydropteroate Synthase Mutants in Recurrent Pneumocystis carinii Pneumonia
Emerging Infectious Diseases, 2003 Failure of sulfa or sulfone prophylaxis is associated with mutations in Pneumocystis carinii gene coding for dihydropteroate synthase (DHPS). The DHPS genotype was analyzed in AIDS patients who had two separate episodes of P. carinii pneumonia.
Aimable Nahimana +6 more
doaj +1 more source
Revista do Instituto de Medicina Tropical de São Paulo, 1990 The goal of this study was to evaluate inhaled pentamidine for the treatment of patients with mild and moderate Pneumocystis carinii pneumonitis. Eight adults with AIDS and pneumocystis pneumonia (4 with a first episode and 4 with a repeat pneumocystosis)
Adriana Weinberg +5 more
doaj +1 more source
Functional Characterization of
mBio, 2016 Fungi in the genus Pneumocystis live in the lungs of mammals, where they can cause a fatal pneumonia (PCP [Pneumocystis pneumonia]) in hosts with compromised immune systems.
Melanie T. Cushion +5 more
doaj +1 more source